<VariationArchive RecordType="classified" VariationID="2577166" VariationName="NM_031844.3(HNRNPU):c.1765del (p.Gln589fs)" VariationType="Deletion" Accession="VCV002577166" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-09-03" DateCreated="2023-08-26" MostRecentSubmission="2023-08-26">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2742066" VariationID="2577166">
      <GeneList>
        <Gene Symbol="HNRNPU" FullName="heterogeneous nuclear ribonucleoprotein U" GeneID="3192" HGNC_ID="HGNC:5048" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q44</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="244850297" stop="244864543" display_start="244850297" display_stop="244864543" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="245013601" stop="245027826" display_start="245013601" display_stop="245027826" Strand="-" />
          </Location>
          <OMIM>602869</OMIM>
          <Haploinsufficiency last_evaluated="2016-09-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=HNRNPU">Some evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2016-09-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=HNRNPU">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_031844.3(HNRNPU):c.1765del (p.Gln589fs)</Name>
      <CanonicalSPDI>NC_000001.11:244856603:GGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q44</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="244856604" stop="244856604" display_start="244856604" display_stop="244856604" variantLength="1" positionVCF="244856603" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="245019906" stop="245019906" display_start="245019906" display_stop="245019906" variantLength="1" positionVCF="245019905" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>Q570fs</ProteinChange>
      <ProteinChange>Q589fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.245019908del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.245019908del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.244856606del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.244856606del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_042184.1" sequenceAccession="NG_042184" sequenceVersion="1" change="g.12922del">
            <Expression>NG_042184.1:g.12922del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004501.3" sequenceAccession="NM_004501" sequenceVersion="3" change="c.1708del">
            <Expression>NM_004501.3:c.1708del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004492.2" sequenceAccession="NP_004492" sequenceVersion="2" change="p.Gln570fs">
            <Expression>NP_004492.2:p.Gln570fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_031844.3" sequenceAccession="NM_031844" sequenceVersion="3" change="c.1765del" MANESelect="true">
            <Expression>NM_031844.3:c.1765del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_114032.2" sequenceAccession="NP_114032" sequenceVersion="2" change="p.Gln589fs">
            <Expression>NP_114032.2:p.Gln589fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_031844.3(HNRNPU):c.1765del (p.Gln589fs) AND Developmental and epileptic encephalopathy, 54" Accession="RCV003324243" Version="2">
        <ClassifiedConditionList TraitSetID="35377">
          <ClassifiedCondition DB="MedGen" ID="C4479319">Developmental and epileptic encephalopathy, 54</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-21" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-08-26" MostRecentSubmission="2023-08-26">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="35377" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="37053" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Epileptic encephalopathy, early infantile, 54</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 54</ElementValue>
                <XRef ID="MONDO:0033363" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DEE54</ElementValue>
                <XRef Type="MIM" ID="617391" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EIEE54</ElementValue>
                <XRef Type="MIM" ID="617391" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">HNRNPU-related neurodevelopmental disorder (HNRNPU-NDD) is characterized by developmental delay and intellectual disability – typically moderate to severe – with speech and language delay and/or absent speech. Affected individuals may also display autistic features. There may be feeding difficulties during the neonatal period as well as hypotonia, which often remains lifelong. Dysmorphic features have been described but they are nonspecific. Affected individuals are likely to experience seizures (most commonly tonic-clonic or absence) that may be refractory to treatment. Nonspecific brain MRI findings include ventriculomegaly and thinning of the corpus callosum. Less common findings include cardiac abnormalities, strabismus, undescended testes in males, renal anomalies, and skeletal features, including joint laxity, polydactyly, and scoliosis. Rarely, abnormal breathing patterns, including hyperventilation and apnea, may be present and can lead to sleep disturbance.</Attribute>
                <XRef ID="NBK578573" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">35274911</ID>
                <ID Source="BookShelf">NBK578573</ID>
              </Citation>
              <XRef ID="C4479319" DB="MedGen" />
              <XRef ID="MONDO:0033363" DB="MONDO" />
              <XRef Type="MIM" ID="617391" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7537995" SubmissionDate="2023-08-25" DateLastUpdated="2023-08-26" DateCreated="2023-08-26">
        <ClinVarSubmissionID localKey="NM_031844.2:c.1765delC|MedGen:C4479319" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004029740" DateUpdated="2023-08-26" DateCreated="2023-08-26" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Variant summary: HNRNPU c.1765delC (p.Gln589ArgfsX17) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 250352 control chromosomes (gnomAD). To our knowledge, no occurrence of c.1765delC in individuals affected with Developmental And Epileptic Encephalopathy, 54 and no experimental evidence demonstrating its impact on protein function have been reported. No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HNRNPU" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_031844.2:c.1765delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4479319" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13795539</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7537995" TraitType="Disease" MappingType="XRef" MappingValue="C4479319" MappingRef="MedGen">
        <MedGen CUI="C4479319" Name="Developmental and epileptic encephalopathy, 54" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

